![Dae-Young Sung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 37 M $ al 30/09/2026
Dae-Young Sung currently works at WITHUS PHARMACEUTICAL Co., Ltd., as Chief Executive Officer & Director.
Dr. Sung received his doctorate degree from Chung-Ang University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 6.922.297 ( 52,44 % ) | 37 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| WITHUS PHARMACEUTICAL CO.,LTD. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
WITHUS PHARMACEUTICAL Co., Ltd.
 WITHUS PHARMACEUTICAL Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells prescription drugs | Health Technology |
Chung-Ang University
 Chung-Ang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
